Background Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge
repair of severe mitral regurgitation, as compared with outcomes after maximal doses of …

Mitral regurgitation is a prevalent valvular disease, and its management has gained
increasing importance due to the aging population. While traditional surgery remains the …

Introduction Over the course of 2021, numerous key clinical trials with valuable contributions
to clinical cardiology were published or presented at major international conferences. This …

PubMed displayed more than 35,000 hits for the search term “cardiac surgery AND 2021.”
We used the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta …

Abstract Background Although> 150,000 mitral TEER procedures have been performed
worldwide, the impact of MR etiology on MV surgery after TEER remains unknown …

OBJECTIVES Tricuspid regurgitation (TR) in patients who had heart transplants is
associated with poor outcome. The increased risk for surgical and postoperative …

Objective The use of transcatheter edge-to-edge repair (TEER) is growing substantially, and
reintervention after TEER by way of repeat TEER or mitral valve surgery (MVS) is increasing …

OBJECTIVES Although clinical experience with transcatheter mitral valve interventions is
rapidly increasing, there is still a lack of evidence regarding surgical treatment options for …

Mitral valve repair is the ideal intervention for mitral valve disease with excellent long-term
survival comparable to the age-matched general population. When the mitral valve is not …

Surgical mitral valve repair in reference centres remain the gold standard and the most
durable treatment for degenerative mitral disease with excellent perioperative safety …